Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneous oblique double random forest.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

The Frontal Air Sinus Analysis in Personal Identification and Gender Differentiation among Adult Bangladeshi.

Mymensingh medical journal : MMJ·2026
Same author

bFuzzy logic-based approach for porcine DNA determination in meat products.

NPJ science of food·2025
Same author

Emerging pollutants in pharmaceutical and personal care product industrial effluents: Characterization and their environmental impacts.

Water science and technology : a journal of the International Association on Water Pollution Research·2025
Same author

Status of the Microbiological Isolates and Antibiotics Susceptibilities in Patients with Auricular Perichondritis.

Mymensingh medical journal : MMJ·2025
Same author

Evaluation of nutritional and techno-functional aspects of black soldier fly high-protein extracts in different developmental stages.

Animal : an international journal of animal bioscience·2025

Related Experiment Video

Updated: Jun 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Metastasis in differentiated thyroid carcinoma.

M A Azim1, K S Salam, M K Khan

  • 1Dr Md Abdul Azim, Junior Consultant, Department of ENT, Mymensingh Medical College Hospital (MMCH), Mymensingh, Bangladesh.

Mymensingh Medical Journal : MMJ
|October 20, 2010
PubMed
Summary

Differentiated thyroid carcinoma (DTC) is more common in females. Papillary carcinoma, the most frequent type, shows higher lymph node metastasis rates, while follicular carcinoma presents more distant metastasis.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Experiment Videos

Last Updated: Jun 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Area of Science:

  • Oncology
  • Otorhinolaryngology

Background:

  • Differentiated thyroid carcinoma (DTC) is a common endocrine malignancy.
  • Understanding the epidemiological and clinical characteristics of DTC is crucial for patient management.

Purpose of the Study:

  • To analyze the epidemiological features and patterns of metastasis in differentiated thyroid carcinoma patients.
  • To compare the characteristics of papillary and follicular carcinoma subtypes.

Main Methods:

  • Retrospective analysis of 70 differentiated thyroid carcinoma patients.
  • Data collected from March 2003 to March 2005 at three medical college hospitals.
  • Evaluation of patient demographics, tumor types, and metastasis patterns.

Main Results:

  • Female patients were more commonly affected (2.6:1 ratio).
  • Papillary carcinoma (77.15%) was more prevalent than follicular carcinoma (22.85%).
  • Lymph node metastasis was higher in papillary (35%) versus follicular (12.5%) carcinoma; distant metastasis was higher in follicular (12.5%) versus papillary (3.70%).
  • Maximum lymph node metastasis occurred in level 3 (55%) and level 2 (45%).

Conclusions:

  • Papillary carcinoma is the predominant subtype of DTC with a higher propensity for lymph node metastasis.
  • Follicular carcinoma shows a greater tendency for distant metastasis.
  • Metastasis patterns differ significantly between papillary and follicular thyroid carcinoma subtypes, influencing clinical management strategies.